Cargando…

Tyrosine Kinase c-MET as Therapeutic Target for Radiosensitization of Head and Neck Squamous Cell Carcinomas

SIMPLE SUMMARY: The overall five-year survival rate of patients with loco-regional advanced head and neck squamous cell carcinomas (HNSCC) is only around 40%. The curability of HNSCC with radiochemotherapy was previously found to be associated with clinical and biological parameters including tumor...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lüttich, Lina, Besso, María José, Heiden, Stephan, Koi, Lydia, Baumann, Michael, Krause, Mechthild, Dubrovska, Anna, Linge, Annett, Kurth, Ina, Peitzsch, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8070694/ https://www.ncbi.nlm.nih.gov/pubmed/33919702 http://dx.doi.org/10.3390/cancers13081865

Ejemplares similares

Prognostic biomarkers for the response to the radiosensitizer nimorazole combined with RCTx: a pre-clinical trial in HNSCC xenografts
por: Koi, Lydia, et al.
Publicado: (2023)

Cancer stem cell related markers of radioresistance in head and neck squamous cell carcinoma
por: Kurth, Ina, et al.
Publicado: (2015)

Oct4 confers stemness and radioresistance to head and neck squamous cell carcinoma by regulating the homologous recombination factors PSMC3IP and RAD54L
por: Nathansen, Jacqueline, et al.
Publicado: (2021)

Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)
por: Rassamegevanon, Treewut, et al.
Publicado: (2021)

Validation of CD98hc as a Therapeutic Target for a Combination of Radiation and Immunotherapies in Head and Neck Squamous Cell Carcinoma
por: Köseer, Ayşe Sedef, et al.
Publicado: (2022)

Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: Identification, Characterization and Clinical Implications
por: Peitzsch, Claudia, et al.
Publicado: (2019)

GLS-driven glutamine catabolism contributes to prostate cancer radiosensitivity by regulating the redox state, stemness and ATG5-mediated autophagy
por: Mukha, Anna, et al.
Publicado: (2021)

Metastatic Spread in Prostate Cancer Patients Influencing Radiotherapy Response
por: Klusa, Daria, et al.
Publicado: (2021)

The c-Met receptor tyrosine kinase inhibitor MP470 radiosensitizes glioblastoma cells
por: Welsh, James W, et al.
Publicado: (2009)

Comparison of the composition of lymphocyte subpopulations in non-relapse and relapse patients with squamous cell carcinoma of the head and neck before, during radiochemotherapy and in the follow-up period: a multicenter prospective study of the German Cancer Consortium Radiation Oncology Group (DKTK-ROG)
por: Niu, Minli, et al.
Publicado: (2021)

Dual role of ER stress in response to metabolic co-targeting and radiosensitivity in head and neck cancer cells
por: Chen, Oleg, et al.
Publicado: (2020)

Specific requirements for translation of biological research into clinical radiation oncology
por: Krause, Mechthild, et al.
Publicado: (2020)

Foretinib Enhances the Radiosensitivity in Esophageal Squamous Cell Carcinoma by Inhibiting Phosphorylation of c-Met
por: Chen, Guang-Zong, et al.
Publicado: (2017)

Efficacy of Beta1 Integrin and EGFR Targeting in Sphere-Forming Human Head and Neck Cancer Cells
por: Zscheppang, Katja, et al.
Publicado: (2016)

Targeting glutamine metabolism and autophagy: the combination for prostate cancer radiosensitization
por: Mukha, Anna, et al.
Publicado: (2021)

2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma
por: Starke, Sebastian, et al.
Publicado: (2020)

Zerumbone acts as a radiosensitizer in head and neck squamous cell carcinoma
por: Schnoell, Julia, et al.
Publicado: (2021)

Independent validation of the prognostic value of cancer stem cell marker expression and hypoxia-induced gene expression for patients with locally advanced HNSCC after postoperative radiotherapy
por: Linge, Annett, et al.
Publicado: (2016)

Radiosensitization approaches for HPV‐positive and HPV‐negative head and neck squamous carcinomas
por: Dok, Rüveyda, et al.
Publicado: (2019)

Photodynamic Therapy as a Potent Radiosensitizer in Head and Neck Squamous Cell Carcinoma
por: Cho, Won Jin, et al.
Publicado: (2021)

Establishment and Characterisation of Heterotopic Patient-Derived Xenografts for Glioblastoma
por: Meneceur, Sarah, et al.
Publicado: (2020)

MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
por: Ramesh, Shrey, et al.
Publicado: (2023)

EGFR Alterations Influence the Cetuximab Treatment Response and c-MET Tyrosine-Kinase Inhibitor Sensitivity in Experimental Head and Neck Squamous Cell Carcinomas
por: Nelhűbel, Györgyi A., et al.
Publicado: (2021)

Retrospective investigation of the prognostic value of the β1 integrin expression in patients with head and neck squamous cell carcinoma receiving primary radio(chemo)therapy
por: Cordes, Nils, et al.
Publicado: (2018)

In vitro and in vivo superior radiosensitizing effect of berbamine for head and neck squamous cell carcinoma
por: Zhu, Hongmei, et al.
Publicado: (2018)

Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data
por: Liu, Jie, et al.
Publicado: (2020)

MiR-125 family improves the radiosensitivity of head and neck squamous cell carcinoma
por: Wang, Qi-Wei, et al.
Publicado: (2023)

Radiosensitizing effect of c-Met kinase inhibitor BPI-9016M in esophageal squamous cell carcinoma cells in vitro and in vivo
por: Jiang, Chenxue, et al.
Publicado: (2021)

The HIV protease and PI3K/Akt inhibitor nelfinavir does not improve the curative effect of fractionated irradiation in PC-3 prostate cancer in vitro and in vivo
por: Liebscher, Steffi, et al.
Publicado: (2017)

Antisense inhibition of ATM gene enhances the radiosensitivity of head and neck squamous cell carcinoma in mice
por: Zou, Jian, et al.
Publicado: (2008)

The Small Molecule Inhibitor QLT0267 Radiosensitizes Squamous Cell Carcinoma Cells of the Head and Neck
por: Eke, Iris, et al.
Publicado: (2009)

Enhancing radiosensitization in EphB4 receptor-expressing Head and Neck Squamous Cell Carcinomas
por: Bhatia, Shilpa, et al.
Publicado: (2016)

Afatinib radiosensitizes head and neck squamous cell carcinoma cells by targeting cancer stem cells
por: Macha, Muzafar A, et al.
Publicado: (2017)

Gene signature for prediction of radiosensitivity in human papillomavirus-negative head and neck squamous cell carcinoma
por: Kim, Su Il, et al.
Publicado: (2020)

Alteration status and prognostic value of MET in head and neck squamous cell carcinoma
por: Cho, Yoon Ah, et al.
Publicado: (2016)

Heat shock protein 70 and tumor‐infiltrating NK cells as prognostic indicators for patients with squamous cell carcinoma of the head and neck after radiochemotherapy: A multicentre retrospective study of the German Cancer Consortium Radiation Oncology Group (DKTK‐ROG)
por: Stangl, Stefan, et al.
Publicado: (2017)

A radiosensitivity MiRNA signature validated by the TCGA database for head and neck squamous cell carcinomas
por: Liu, Ning, et al.
Publicado: (2015)

Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic–induced necroptosis
por: Uzunparmak, Burak, et al.
Publicado: (2020)

Integrating Intrinsic Radiosensitivity and Immune Status for Predicting Benefits of Radiotherapy in Head and Neck Squamous Cell Carcinoma
por: Sun, Chuyao, et al.
Publicado: (2021)

Effectiveness of PARP inhibition in enhancing the radiosensitivity of 3D spheroids of head and neck squamous cell carcinoma
por: Zhou, Chumin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qa9lmfh27pvkj41kgrh658u2q6